Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Research on ambidextrous digital innovation strategies of SMEs embedded in industrial internet platforms based on evolutionary game theory. [PDF]
Zhuang C, Lin Y, Wang L.
europepmc +1 more source
Benefits, Adoption Barriers and Myths of Open Data and Open Government
M. Janssen +2 more
semanticscholar +1 more source
Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen +11 more
wiley +1 more source
Government policy attention to aging and mental health among middle aged and older adults: A text-based analysis of chinese municipal reports. [PDF]
Zhuo C, Dai L, Deng Y.
europepmc +1 more source
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund +3 more
wiley +1 more source
Pathways to promote the performance of healthcare financial expenditure from an audit perspective: Evidence from Hunan Province. [PDF]
Ling S, Tang X, Shi Q.
europepmc +1 more source

